Back to HomeBeta

ICD-10 Coding for Mediastinal Lymphadenopathy(R59.0, C78.2)

Complete ICD-10-CM coding and documentation guide for Mediastinal Lymphadenopathy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Swollen Mediastinal Lymph NodesMediastinal Lymph Node Enlargementenlarged mediastinal lymph nodesmediastinal adenopathy

Related ICD-10 Code Ranges

Complete code families applicable to Mediastinal Lymphadenopathy

R59Primary Range

Enlarged lymph nodes

Covers general lymphadenopathy including mediastinal when specific cause is unknown.

Secondary malignant neoplasm of respiratory and digestive organs

Used when mediastinal lymphadenopathy is due to metastasis.

Sarcoidosis

Applicable when sarcoidosis is the cause of mediastinal lymphadenopathy.

Respiratory tuberculosis

Used when tuberculosis is the cause of mediastinal lymphadenopathy.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
R59.0Localized enlarged lymph nodesUse when mediastinal lymphadenopathy is localized and no specific cause is identified.
  • Imaging-confirmed mediastinal lymph node enlargement
  • Biopsy results if available
C78.2Secondary malignant neoplasm of mediastinumUse when mediastinal lymphadenopathy is due to metastasis.
  • Histopathology confirming metastasis
  • Imaging showing metastatic spread

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for mediastinal lymphadenopathy

Essential facts and insights about Mediastinal Lymphadenopathy

The ICD-10 code for mediastinal lymphadenopathy is R59.0 for localized cases. Use C78.2 if due to metastasis.

Primary ICD-10-CM Codes for mediastinal lymphadenopathy

Localized enlarged lymph nodes
Billable Code

Decision Criteria

clinical Criteria

  • Mediastinal lymph node enlargement confirmed by imaging

documentation Criteria

  • Location and size of lymph nodes must be documented

Applicable To

  • Localized lymphadenopathy

Excludes

  • Generalized lymphadenopathy (R59.1)

Clinical Validation Requirements

  • Imaging-confirmed mediastinal lymph node enlargement
  • Biopsy results if available

Code-Specific Risks

  • Risk of using R59.9 when location is specified

Coding Notes

  • Ensure documentation specifies mediastinal location.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Abnormal findings on diagnostic imaging of other specified body structures

R93.1
Use for abnormal imaging findings related to mediastinal lymph nodes.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Generalized enlarged lymph nodes

R59.1
Use R59.1 if lymphadenopathy is not localized to the mediastinum.

Malignant neoplasm of unspecified part of bronchus or lung

C34.9
Use C34.9 for primary lung cancer, not secondary.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Mediastinal Lymphadenopathy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R59.0.

Impact

Clinical: Inaccurate diagnosis and treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.

Mitigation Strategy

Ensure biopsy results are included in the medical record., Cross-check documentation before submission.

Impact

Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding specificity requirements., Data Quality: Decreased accuracy in clinical data reporting.

Mitigation Strategy

Use R59.0 for localized mediastinal lymphadenopathy.

Impact

Failure to sequence primary and secondary codes correctly.

Mitigation Strategy

Review coding guidelines for sequencing rules.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Mediastinal Lymphadenopathy, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Mediastinal Lymphadenopathy

Use these documentation templates to ensure complete and accurate documentation for Mediastinal Lymphadenopathy. These templates include all required elements for proper coding and billing.

Lung cancer with mediastinal metastasis

Specialty: Oncology

Required Elements

  • Primary cancer site
  • Metastatic site
  • Biopsy results

Example Documentation

Patient with stage IIIB NSCLC presents with mediastinal lymphadenopathy. Biopsy confirms metastatic adenocarcinoma.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Enlarged lymph nodes in chest.
Good Documentation Example
CT shows 2.1 cm subcarinal lymph node, biopsy confirms metastatic adenocarcinoma.
Explanation
Good example specifies location, size, and biopsy results.

Need help with ICD-10 coding for Mediastinal Lymphadenopathy? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more